Low dose quetiapine in the treatment of an adolescent with somnambulism: A case report

Acta Neurologica Belgica

Volumn 111, Issue 2, 2011, Pages 155-156

  Gill, Jesjeet Singh ^a   Pillai, Subash Kumar ^a   Koh, Ong Hui ^a   Jambunathan, Stephen Thevanathan ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

QUETIAPINE;

ADOLESCENT; ARTICLE; BEDTIME DOSAGE; CASE REPORT; DELTA RHYTHM; FOLLOW UP; HUMAN; LOW DRUG DOSE; MALE; PATHOPHYSIOLOGY; SLEEP WALKING;

EID: 79959457479     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Glaze DG, Rosen CL, Owens JA. Toward a practical definition of pediatric insomnia. Current Therapeutic Research. 2002;63(S2):b4-b7.
2. Frölich J, Wiater A, Lehmkuhl G. Successful treatment of severe parasomnias with paroxetine in a 12-year-old boy int J Psychiatr Clin Pract. 2001;5:215-218.
3. Hafeez ZH, Kalinowski CM. Somnambulism induced by quetiapine: two case reports and a review of the literature. CnS Spectrums. 2007;12:910-9122.
4. Wine JN, Sanda C, Caballero J, The annals of Pharmacotherapy. 2009;43:707-713.
5. Cohrs S, Rodenbeck A, Guan Z, Pohlmann K, Jordan W., et al. Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacology. 2004;174(3):421-429.
6. Swanson J, ed. Sleep Disorders Sourcebook. mi, Omnigraphics; 1999.
7. Wetzel H, Szegedi A, Hain CH, Wiesner J, Schlegel S., et al. Seroquel (iCi 204 636), a putative "atypical" antipsychotic, in schizophrenia with positive symptomatology: results of an open clinical trial and changes of neuroendocrinological and EEG parameters. Psychopharmacology. 2003;119:231-238.
8. Winters HR, Earley WR, Hamer-maansson JE, Davis PC, Smith MA. Steady-State Pharmacokinetic, Safety, and Tolerability Profiles of Quetiapine, norquetiapine, and Other Quetiapine metabolites in Pediatric and adult Patients with Psychotic Disorders. J Child adol Psychopharmacol. 2008;18(1):81-98.